Project Grant HT94252410370
Award Date 6/1/24
Completion Date 5/31/26
Dollars Obligated $5.8M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
- The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
- The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
- This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
- The Defense Health Agency awarded a $1,407,634.00 Project Grant to The Johns Hopkins University on September 1, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BLAST-EXPOSURE OUTCOMES AND ASSOCIATED LONG-TERM SYMPTOM TRAJECTORIES RELATED TO ESSENTIAL RECOVERY-PATHWAYS (BOLSTER) BIOMARKER INITIATIVE," will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
- The Johns Hopkins University will receive $180,072 under a three-year Project Grant award from the Department of the Army Medical Command to investigate the pathobiological role of dysregulated pulmonary vascular metabolism in systemic sclerosis-associated pulmonary arterial hypertension. The grant is funded through the Military Medical Research and Development program administered by the Department of Defense, with a focus on transforming health care for service members and the public through...
- The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
- The Johns Hopkins University was awarded a $806,712 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to investigate exosomal activity in military personnel and its relationship to perivascular space and sleep metrics indicators. Through this research, the University aims to advance understanding of medical solutions for battlefield...
- This Project Grant award of $320,165.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research at The Johns Hopkins University focused on the social determinants of health, biological aging, and disease course in multiple sclerosis. The project aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to critical health challenges. As a leading...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...